Fundz
Real-time · AI · Cross-signal

Renalytix just moved. Here's exactly what to do next.

Who to reach, what to say, and why now — on Renalytix, plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your planRequest a demo
▶
Watch the 2-minute tour · with sound

Renalytix PLC and Carna Health Form Partnership to Enhance Kidney Disease Management through Innovative Digital Health Solutions.

May 12, 2026•21 days ago

Contract Type

partnership

New YorkBiotechnology

Description

Renalytix PLC has partnered with Carna Health to integrate their technologies, aiming to improve the identification and management of chronic kidney disease. This partnership will leverage advanced digital health tools to provide personalized care and enhance patient outcomes.

Company Information

Company

Renalytix

Location

New York, New York, United States

About

Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosis™ for kidney health. We’ve engineered a proprietary solution that successfully enables early-stage, progression risk assessment when it counts the most.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Renalytix's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months